We are live on ! Find out more
NFA

Nationwide Fund Advisors Portfolio holdings

AUM $2.42B
1-Year Est. Return 17.68%
This Fund
S&P 500
This Quarter Est. Return
+1.62%
1 Year Est. Return
+17.68%
3 Year Est. Return
+28.25%
5 Year Est. Return
+4.07%
10 Year Est. Return
+82.68%
AUM
$23B
AUM Growth
-$294M
Cap. Flow
-$302M
Cap. Flow %
-1.31%
Top 10 Hldgs %
10.05%
Holding
3,336
New
91
Increased
1,121
Reduced
1,460
Closed
84

Top Buys

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$34.1M
2
CMCSA icon
Comcast
CMCSA
+$34.1M
3
XRAY icon
Dentsply Sirona
XRAY
+$34.1M
4
BAX icon
Baxter International
BAX
+$31.6M
5
JNJ icon
Johnson & Johnson
JNJ
+$27.7M

Top Sells

Rank Stock Value
1
MA icon
Mastercard
MA
+$42.9M
2
CTSH icon
Cognizant
CTSH
+$38.1M
3
BRCM
BROADCOM CORP CL-A
BRCM
+$34.6M
4
WEC icon
WEC Energy
WEC
+$34.5M
5
AMZN icon
Amazon
AMZN
+$34.1M

Sector Composition

Rank Sector Weight
1 Technology 15.39%
2 Healthcare 13.62%
3 Financials 13.32%
4 Industrials 11.99%
5 Consumer Discretionary 10.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BTU
3051
DELISTED
PEABODY ENERGY CORP COM STK NEW (DE)
BTU
$33K ﹤0.01%
14,031
TESS
3052
DELISTED
Tessco Technologies Inc
TESS
$32K ﹤0.01%
1,910
ORM
3053
DELISTED
Owens Realty Mortgage, Inc.
ORM
$32K ﹤0.01%
+2,000
New +$28.9K
DMTX
3054
DELISTED
Dimension Therapeutics, Inc
DMTX
$32K ﹤0.01%
4,052
+1,263
+45% +$9.95K
AINC
3055
DELISTED
Ashford Inc.
AINC
$31K ﹤0.01%
674
VMEM
3056
DELISTED
VIOLIN MEMORY, INC.
VMEM
$31K ﹤0.01%
14,837
AST
3057
DELISTED
Asterias Biotherapeutics Inc. Series A
AST
$31K ﹤0.01%
6,657
ITIC
3058
Investors Title Co
ITIC
$551M
$30K ﹤0.01%
330
VOO icon
3059
Vanguard S&P 500 ETF
VOO
$993B
$30K ﹤0.01%
+160
New +$28.6K
RPT
3060
Rithm Property Trust
RPT
$95.1M
$30K ﹤0.01%
466
KIN
3061
DELISTED
Kindred Biosciences, Inc.
KIN
$30K ﹤0.01%
8,600
+600
+8% +$2.12K
CORI
3062
DELISTED
Corium International, Inc.
CORI
$30K ﹤0.01%
7,657
+1,515
+25% +$7.96K
LAYN
3063
DELISTED
Layne Christensen Co
LAYN
$30K ﹤0.01%
4,132
TPLM
3064
DELISTED
Triangle Petroleum Corporation
TPLM
$30K ﹤0.01%
55,918
PTX
3065
DELISTED
Pernix Therapeutics Holdings, Inc.
PTX
$30K ﹤0.01%
2,826
EFA icon
3066
iShares MSCI EAFE ETF
EFA
$78.4B
$29K ﹤0.01%
+500
New +$27.6K
VYGR icon
3067
Voyager Therapeutics
VYGR
$181M
$29K ﹤0.01%
3,373
NWY
3068
DELISTED
New York & Co Inc
NWY
$29K ﹤0.01%
7,295
NYNY
3069
DELISTED
Empire Resorts, Inc.
NYNY
$29K ﹤0.01%
2,093
+1
+0% +$14
AP icon
3070
Ampco-Pittsburgh
AP
$170M
$28K ﹤0.01%
2,015
STRL icon
3071
Sterling Infrastructure
STRL
$18.8B
$28K ﹤0.01%
5,417
AREX
3072
DELISTED
Approach Resources Inc.
AREX
$27K ﹤0.01%
23,533
-3,447
-13% -$3.92K
HBCP icon
3073
Home Bancorp
HBCP
$567M
$26K ﹤0.01%
983
PCMI
3074
DELISTED
PCM, Inc
PCMI
$26K ﹤0.01%
3,273
APIC
3075
DELISTED
Apigee Corporation Common Stock
APIC
$26K ﹤0.01%
3,085

Similar funds

Nationwide Fund Advisors's Q1 2016 Portfolio in Review

As of Q1 2016, Nationwide Fund Advisors held 3,336 positions worth $23B, down 1.3% from $23.3B the previous quarter. Its ten largest holdings account for 10% of the portfolio.

Nationwide Fund Advisors's Q1 2016 filing shows 91 new, 1,121 increased, 1,460 reduced and 84 closed positions. Its largest new stake was iShares Russell 1000 Growth ETF: 400,000 shares worth $9.98M. The largest sale was Mastercard, an estimated $42.9M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 15% a quarter earlier, followed by Healthcare and Financials.

  • Nationwide Fund Advisors's largest Q1 2016 buy was iShares Russell 1000 Growth ETF: 400,000 shares worth $9.98M.
  • Nationwide Fund Advisors added most to AbbVie in Q1 2016, an estimated $34.1M increase.
  • Nationwide Fund Advisors's biggest Q1 2016 reduction was Mastercard, cutting an estimated $42.9M.
  • Nationwide Fund Advisors fully exited BROADCOM CORP CL-A in Q1 2016, selling an estimated $34.6M.
  • Nationwide Fund Advisors's ten largest holdings make up 10% of its $23B portfolio in Q1 2016.
  • Nationwide Fund Advisors opened 91 new positions and closed 84 in Q1 2016.
  • Nationwide Fund Advisors's portfolio value fell 1.3% quarter-over-quarter to $23B.

Based on Nationwide Fund Advisors's 13F filing for Q1 2016, filed 5 May 2016.